[go: up one dir, main page]

CL2009000460A1 - Use of a carboxylate with sulfur, selenium, so or so2 group atoms to prepare compositions to prevent or treat inflammation of the skeletal and cardiac muscle (hsmi) of fish, and / or to reduce the mortality of fish with hsmi or that are susceptible to hsmi; fish food comprising said compound. - Google Patents

Use of a carboxylate with sulfur, selenium, so or so2 group atoms to prepare compositions to prevent or treat inflammation of the skeletal and cardiac muscle (hsmi) of fish, and / or to reduce the mortality of fish with hsmi or that are susceptible to hsmi; fish food comprising said compound.

Info

Publication number
CL2009000460A1
CL2009000460A1 CL2009000460A CL2009000460A CL2009000460A1 CL 2009000460 A1 CL2009000460 A1 CL 2009000460A1 CL 2009000460 A CL2009000460 A CL 2009000460A CL 2009000460 A CL2009000460 A CL 2009000460A CL 2009000460 A1 CL2009000460 A1 CL 2009000460A1
Authority
CL
Chile
Prior art keywords
hsmi
fish
skeletal
mortality
selenium
Prior art date
Application number
CL2009000460A
Other languages
Spanish (es)
Inventor
Rorvik Kjell-Arne
Alne Henriette
Thomassen Magni
Original Assignee
Thia Medica As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thia Medica As filed Critical Thia Medica As
Publication of CL2009000460A1 publication Critical patent/CL2009000460A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K40/00—Shaping or working-up of animal feeding-stuffs
    • A23K40/30—Shaping or working-up of animal feeding-stuffs by encapsulating; by coating
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/80—Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Virology (AREA)
  • Insects & Arthropods (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Uso de un carboxilato con átomos de azufre, selenio, grupo so o so2 para preparar composiciones para prevenir o tratar la inflamación del músculo esquelético y cardiaco (hsmi) de los peces, y/o para reducir la mortalidad de los peces con hsmi o que son suceptibles a hsmi; alimento para peces que comprende dicho compuesto.Use of a carboxylate with sulfur, selenium, so or so2 group atoms to prepare compositions for preventing or treating inflammation of the skeletal and cardiac muscle (hsmi) of fish, and / or to reduce the mortality of fish with hsmi or that they are susceptible to hsmi; fish food comprising said compound.

CL2009000460A 2008-02-27 2009-02-27 Use of a carboxylate with sulfur, selenium, so or so2 group atoms to prepare compositions to prevent or treat inflammation of the skeletal and cardiac muscle (hsmi) of fish, and / or to reduce the mortality of fish with hsmi or that are susceptible to hsmi; fish food comprising said compound. CL2009000460A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO20081040A NO20081040L (en) 2008-02-27 2008-02-27 Reduced HSMI mortality

Publications (1)

Publication Number Publication Date
CL2009000460A1 true CL2009000460A1 (en) 2010-02-05

Family

ID=41003478

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2009000460A CL2009000460A1 (en) 2008-02-27 2009-02-27 Use of a carboxylate with sulfur, selenium, so or so2 group atoms to prepare compositions to prevent or treat inflammation of the skeletal and cardiac muscle (hsmi) of fish, and / or to reduce the mortality of fish with hsmi or that are susceptible to hsmi; fish food comprising said compound.

Country Status (4)

Country Link
EP (1) EP2257282A2 (en)
CL (1) CL2009000460A1 (en)
NO (2) NO20081040L (en)
WO (1) WO2009108067A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO341929B1 (en) * 2009-09-14 2018-02-19 Chemoforma Ltd Feed composition
NO347765B1 (en) * 2012-11-01 2024-03-18 Ewos Innovation As Feed composition for fish

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2570050C (en) * 2004-06-11 2013-03-05 Pharmaq As Heart and skeletal muscle inflammation (hsmi) virus
AU2005264781B2 (en) * 2004-07-19 2011-07-28 Life Science Nutrition As Composition comprising plant and/or fish oils and non-oxidizable fatty acid entities
NO20055541L (en) * 2005-11-23 2007-05-24 Berge Biomed As Use of fatty acid analogues

Also Published As

Publication number Publication date
NO20081040L (en) 2009-08-28
NO20101223L (en) 2010-09-02
EP2257282A2 (en) 2010-12-08
WO2009108067A3 (en) 2009-11-12
WO2009108067A2 (en) 2009-09-03

Similar Documents

Publication Publication Date Title
CL2013001093A1 (en) Tricyclic compounds that inhibit the kinase pi3 (pi3k); pharmaceutical composition that includes them; method to treat cancer; and its use for the treatment of cancer.
ECSP13012618A (en) DERIVATIVES OF 2,3-DIHYDROIMIDAZO [1,2-C] QUINAZOLINA SUBSTITUTED WITH AMINOALCOHOLES THAT ARE USEFUL TO TREAT HYPERPROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS
CL2013001567A1 (en) Combinations of active ingredients comprising pyridylethylbenzamides; procedure to combat animal pests; use of the combination to treat seeds.
DOP2018000241A (en) SULFONAMIDE AROMATIC DERIVATIVES
MX391850B (en) COMPOUNDS FOR USE IN THE TREATMENT OR AMENDING OF HUNTINGTON'S DISEASE
SV2017005461A (en) BENZAMIDS REPLACED WITH 1,3-TIAZOL-2-ILO
MX2016008462A (en) Modulation of angiopoietin-like 3 expression.
CL2012003415A1 (en) Compounds derived from 2-oxo-piperidine and 1,1-dioxide-thiazine, mdm2 inhibitors; pharmaceutical composition that includes them; and its use for the treatment of cancer.
EA201690406A1 (en) GRP94 SELECTIVE INHIBITORS AND METHODS OF THEIR APPLICATION
CL2011000527A1 (en) Compounds derived from benzofuran; pharmaceutical composition that includes them; and their use in the treatment of hepatitis c.
CL2014000801A1 (en) Variant of human fibroblast growth factor 21 (fgf21); pharmaceutical composition that includes it; and its use to treat type 2 diabetes, obesity, dyslipidemia, metabolic syndrome or any combination thereof.
CL2008003265A1 (en) Compounds derived from nitrogenous heterocycles, suppressors of collagen production; pharmaceutical composition comprising said compounds; and its use to prevent and / or treat fibrosis and / or tumors.
EA201691194A1 (en) RHC STIMULATORS
BR112017007708A2 (en) macrocyclic compound, use of a macrocyclic compound, method of treatment, unit dose, pharmaceutical composition and method of treating cancer in a patient
BRPI0806517A2 (en) Method for hatching hatching eggs, composition formulated for the treatment of hatching eggs before incubation, and use of a composition
BR112018013011A2 (en) pet food compositions
CU20120171A7 (en) SUBSTITUTED TRIAZOLOPIRIDINS
NI201500118A (en) SUBSTITUTE IMIDAZOPYRIDAZINES
ECSP21026021A (en) PNPLA3 EXPRESSION MODULATORS
UY35293A (en) ISOTIAZOLES REPLACED WITH AMINO
DOP2016000007A (en) SUBSTITUTED PIRAZOLPIRIDINS
MX2018009408A (en) Rapaglutins, novel inhibitors of glut and use thereof.
ES2508165T3 (en) Lactoferrin and white matter
CR20150653A (en) NEW COMPOUNDS FOR CANCER TREATMENT
CL2007001514A1 (en) Compounds derived from triazine or diazine substituted by chromane or isochroman, hsp90 inhibitors; pharmaceutical composition comprising; and its use in the treatment of cancer.